INTELLIA THERAPEUTICS, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2021-02-26: Form 10-K; Item Current in its reporting; As filed No.
- 2020-02-27: Form 10-K; Item Current in its reporting; As filed No.
- 2019-02-27: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2018-10-31: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2021-02-26 | 10-K | Current in its reporting | No |
| 2020-02-27 | 10-K | Current in its reporting | No |
| 2019-02-27 | 10-K | Well-known seasoned issuer | No |
| 2018-10-31 | 10-Q | Emerging growth company | Yes |
| 2018-03-14 | 10-K | Well-known seasoned issuer | No |
| 2017-03-14 | 10-K | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |